Intratumor heterogeneity is one of the reasons for this discordance, suggesting that both KRAS wild-type and mutant subpopulations of cells may coexist within the same tumour and compete with one another for shedding into the bloodstream. This evidence concerns the gene KRAS and neoplasm.